Planta Medica · 2004 · 23 citations · 0 references
Life SciencesBotanyMicrobiologyDrug DiscoveryMycologyPlant BiochemistryAntifungal AgentsFungal BiochemistryFungal Cell BiologyFungal Natural Product BiosynthesisFungal PathogenesisFungal Secondary MetabolitesFungal Bioactive CompoundsFungal Cell Wall BiologyFungal Cell WallsFungal Drug DiscoveryLectinsNatural Antifungal CompoundsNew Antifungal AgentsNovel Antifungal Drug Development
Among the different xanthones previously isolated from the stem bark of Calophyllum caledonicum, caledonixanthone E presented the strongest activity (MIC (80) = 8 microg/mL) in acidic conditions (pH 3) against the human pathogenic fungus Aspergillus fumigatus. Phase-contrast microscopy studies suggested the assembly or synthesis of cell wall components as the target of the drug. Moreover, the use of fluorescent lectins further supported an impact of caledonixanthone E on the synthesis of chitin, the major structural polysaccharide of the fungal wall. These results suggest that caledonixanthone E may be an interesting model for the design of new antifungal drugs.